Research
IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer
-
* Corresponding author: John A Martignetti john.martignetti@mssm.edu
1 Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY, USA
2 Division of Gynecologic Oncology, Mount Sinai School of Medicine, New York, NY, USA
3 Prognosys Biosciences, La Jolla, California, USA
4 San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy
5 Department of Oncology, Instituto "Mario Negri", Milano, Italy
6 Mario Negri Gynecological Oncology Group (MaNGO), Milano, Italy
Journal of Ovarian Research 2012, 5:3 doi:10.1186/1757-2215-5-3
Published: 20 January 2012Additional files
Additional file 1:
Table S1. Supplementary Table 1: Patient and tumor demographics.
Format: PDF Size: 222KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 2:
Table S2. Supplementary Table 2: Patient demographic and chemotherapeutic data.
Format: PDF Size: 222KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 3:
Table S3. Supplementary Table 3: qRT-PCR tumor coverage values.
Format: PDF Size: 222KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 4:
Figure S1. Serum IGFBP-4 levels are not significantly correlated with age. Scatter plot of serum IGFBP-4 levels against age of both cases and controls shows no correlation between to the two.
Format: JPEG Size: 168KB Download file
Additional file 5:
Table S4. Supplementary Table 4: IGFBP-4 and age by ethnicity.
Format: PDF Size: 145KB Download file
This file can be viewed with: Adobe Acrobat Reader